tiprankstipranks
ImmunityBio (IBRX)
NASDAQ:IBRX
US Market

ImmunityBio (IBRX) Cash flow

Compare
1,306 Followers

ImmunityBio Cash Flow

IBRX's free cash flow for Q4 2024 was $-85.14M. For the 2024 fiscal year, IBRX's free cash flow was decreased by $-783.00K and operating cash flow was $-85.14M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -391.24M$ -366.76M$ -337.51M$ -274.42M$ -171.72M
Investing Cash Flow
$ -12.25M$ -30.47M$ 27.30M$ -84.89M$ -19.81M
Financing Cash Flow
$ 281.63M$ 558.34M$ 233.61M$ 505.44M$ 150.68M
End Cash Position
$ 143.91M$ 265.79M$ 104.97M$ 181.28M$ 35.09M
Free Cash Flow
$ -398.12M$ -397.34M$ -436.90M$ -307.98M$ -173.39M
Currency in USD

ImmunityBio Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis